Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.

Villegas, S L; Darb-Esfahani, S; von Minckwitz, G; Huober, J; Weber, K; Marmé, F; Furlanetto, J; Schem, C; Pfitzner, B M; Lederer, B; Engels, K; Kümmel, S; Müller, V; Mehta, K; Denkert, C; Loibl, S

Villegas, S L; Darb-Esfahani, S; von Minckwitz, G; Huober, J; Weber, K; Marmé, F; Furlanetto, J; Schem, C; Pfitzner, B M; Lederer, B; Engels, K; Kümmel, S; Müller, V; Mehta, K; Denkert, C; Loibl, S.

Afiliación

Villegas SL; Institute of Pathology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Darb-Esfahani S; Institute of Pathology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
von Minckwitz G; Institute of Pathology Spandau, Evangelisches Waldkrankenhaus, Stadtrandstr. 555, 13589, Berlin, Germany.
Huober J; German Breast Group (GBG Forschungs GmbH), Martin-Behaim-Str. 12, 63263, Neu-Isenburg, Germany.
Weber K; Department of Obstetrics and Gynecology, Ulm University, Ulm, Germany.
Marmé F; German Breast Group (GBG Forschungs GmbH), Martin-Behaim-Str. 12, 63263, Neu-Isenburg, Germany.
Furlanetto J; National Center for Tumor Diseases, University-Hospital Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
Schem C; German Breast Group (GBG Forschungs GmbH), Martin-Behaim-Str. 12, 63263, Neu-Isenburg, Germany.
Pfitzner BM; Department of Gynecology and Obstetrics, University Hospital Schleswig-Hostein, Kiel, Germany.
Lederer B; Institute of Pathology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Engels K; German Breast Group (GBG Forschungs GmbH), Martin-Behaim-Str. 12, 63263, Neu-Isenburg, Germany.
Kümmel S; Zentrum für Pathologie, Zytologie und Molekularpathologie Neuss, Neuss, Germany.
Müller V; Breast Unit Kliniken Essen-Mitte, Essen, Germany.
Mehta K; Department of Gynecology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Denkert C; German Breast Group (GBG Forschungs GmbH), Martin-Behaim-Str. 12, 63263, Neu-Isenburg, Germany.
Loibl S; Institute of Pathology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. carsten.denkert@charite.de.

Breast Cancer Res Treat ; 168(1): 179-187, 2018 Feb.

Article en En | MEDLINE | ID: mdl-29177689

Asunto(s)

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Biomarcadores de Tumor/metabolismo; Neoplasias de la Mama/terapia; Mama/patología; Ciclina D1/metabolismo; Adulto; Biomarcadores de Tumor/análisis; Mama/citología; Mama/cirugía; Neoplasias de la Mama/mortalidad; Neoplasias de la Mama/patología; Núcleo Celular/metabolismo; Ciclina D1/análisis; Supervivencia sin Enfermedad; Femenino; Perfilación de la Expresión Génica/métodos; Humanos; Mastectomía; Persona de Mediana Edad; Terapia Neoadyuvante/métodos; Neoplasia Residual; Pronóstico; Receptor ErbB-2/metabolismo; Receptores de Estrógenos/metabolismo; Receptores de Progesterona/metabolismo; Estudios Retrospectivos; Análisis de Matrices Tisulares/métodos

Palabras clave

Breast cancer; Cyclin D-CDK4/CDK6; Cyclin D1; Cyclin D1 TMA; Cyclin D1 overexpression; Neoadjuvant chemotherapy; Prognose Cyclin D1

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mama / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Ciclina D1 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google